Stock data
Neurocrine Biosciences, Inc. (NBIX)
Neurocrine Biosciences, Inc. (NBIX) reported revenue of US$2.86B and net income of US$478.60M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$2.86B | — | US$619.10M | US$478.60M | — |
| 2024 | US$2.36B | — | US$570.50M | US$341.30M | — |
| 2023 | US$1.89B | — | US$250.90M | US$249.70M | — |
| 2022 | US$1.49B | — | US$249.00M | US$154.50M | — |
| 2021 | US$1.13B | — | US$102.50M | US$89.60M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$959.00M | US$144.40M | — |
| 2026-03-31 | US$814.50M | US$197.90M | — |
| 2025-12-31 | US$805.50M | US$153.70M | — |
| 2025-09-30 | US$794.90M | US$209.50M | — |
| 2025-06-30 | US$687.50M | US$107.50M | — |
| 2025-03-31 | US$572.60M | US$7.90M | — |
| 2024-12-31 | US$627.70M | US$103.10M | — |
| 2024-09-30 | US$622.10M | US$129.80M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.